SSM, UnityPoint Health collaborate to produce generic antibiotics

CivicaRx, a Utah-based company comprised of a group of U.S. health systems and hospitals — including SSM Health and UnityPoint Health — announced the first two generic drugs it will produce: Vancomycin and Daptomycin, antibiotics used to treat difficult infections.

CivicaRx is looking to increase the supply of at least 14 essential medications that have been in short supply or too expensive, according to a release.

CivicaRx will partner with Xellia Pharmaceuticals, a Denmark drug manufacturer, to produce the generics. St. Louis-based SSM Health owns St. Mary’s Hospital and Dean Medical Group in Madison.